Key Highlights

  • The five are ordered by pre-market gain in the Wednesday, October 28, 2026 snapshot, from Ultralife Corporation (NASDAQ:ULBI) at 143.87% down to NewGenIvf Group Limited (NASDAQ:NIVF) at 21.30%.
  • Only two of the moves trace to a dated company release: the EnerSys cash offer for Ultralife, disclosed Tuesday, October 27, 2026, and the distribution agreement of Elong Power Holding Limited (NASDAQ:ELPW), disclosed Wednesday, October 28, 2026.
  • Braiin Limited (NASDAQ:BRAI) and Davion Healthcare Plc (NASDAQ:DAVI) rose 40.18% and 39.00% without a dated announcement, which points toward momentum and rebound buying.
  • Four of the five trade between USD 1.40 and USD 4.64, so these gains rest on thin liquidity and could reverse before the 9:30 a.m. ET open.

Ultralife Corporation (NASDAQ:ULBI): a fixed cash price anchors the stock

Batteries, energy products and communications systems are the business lines of Ultralife Corporation (NASDAQ:ULBI). Its stock surged 143.87% to USD 15.51. The driver was Tuesday's release, in which EnerSys agreed to acquire every share for USD 16.00 in cash, a takeover valued near USD 320 million including assumed net debt. Management framed that price as a 166% premium over the Monday, October 26, 2026 close, which puts the prior close around USD 6.02. The snapshot gain points to about USD 6.36, so the true prior close sits between those two marks.

With a cash price locked in, trading now hinges on how likely and how quickly the deal closes, rather than on quarterly results. Second-quarter revenue was USD 47.9 million, down 1.3%, with EPS of USD 0.15. Pre-market quotes sit close to 3.1% beneath the offer, a figure derived from two published prices. The tender must start, win a majority of tendered shares and clear regulators, and closing is expected in the first quarter of calendar 2027.

Braiin Limited (NASDAQ:BRAI): a second leg up after the Force AI launch

Braiin Limited (NASDAQ:BRAI) runs the RADIUS contact-centre platform from Australia. Shares climbed 40.18% to USD 4.64. Backing out the gain gives a prior close near USD 3.31, but market data put the close before the launch at USD 2.12, implying a rise of roughly 56% across Tuesday, October 27, 2026's regular session. The newest announcement, dated Monday, October 26, 2026, concerned global availability of Force AI.

The announcement carried no income statement. Its headline metric, over 4.5 million interactions handled at 99.9% uptime in the twelve months to Tuesday, March 31, 2026, comes from selected deployments and is indicative only. A free float of roughly 29.68 million shares is cited, a small base. With no customer, price or revenue contribution disclosed, product novelty and light trading seem to explain the move.

Davion Healthcare Plc (NASDAQ:DAVI): a rebound from a sharp fall

Davion Healthcare Plc (NASDAQ:DAVI) develops non-invasive tests for home screening and is based in Ireland. Its shares advanced 39.00% to USD 4.17, clawing back part of a steep slide on Tuesday, October 27, 2026. Working backwards gives a prior close near USD 3.00, while that Tuesday's pre-market level was about USD 3.71. Monday, October 26, 2026's release covered buying Humaskan intellectual property for USD 2.5 million in cash and 1,730,770 new shares priced at USD 13.00 each, so a bounce on thin volume fits.

No revenue has been booked, and the registration document showed EUR 1.3 million of operating losses for fiscal 2024. Because the share count is fixed, the sellers' payout tracks the market price, and the new shares are due for issue on Wednesday, January 20, 2027. Risks flagged include dilution, a five-year senior secured bond of GBP 30 million and the fact that its tests are not diagnostic. The stock has traded only since Thursday, October 22, 2026.

Elong Power Holding Limited (NASDAQ:ELPW): a USD 25.5 million distribution deal

Elong Power Holding Limited (NASDAQ:ELPW) divested its lithium battery unit in March 2026 and now reports distribution income. Shares rose 38.11% to USD 3.37, a prior close near USD 2.44 consistent with market data. The catalyst came from a Wednesday, October 28, 2026 release: its Hong Kong subsidiary inked a one-year cooperation pact worth USD 25.5 million to distribute smart consumer electronics, starting with a first delivery of about USD 0.84 million. The pact renews automatically unless either side objects.

Half-year revenue of USD 2,899,110 for the six months to Tuesday, June 30, 2026 makes that USD 25.5 million contract look sizeable, but gross profit amounted to just USD 8,994, a 0.3% margin. Net income of USD 20,494,107 was boosted by a one-off disposal gain instead of operations. Reverse splits of 1-for-80 and 1-for-45 happened in 2026, offerings were priced in July and August 2026, and a float near 805,500 shares keeps dilution and Nasdaq compliance on the agenda.

NewGenIvf Group Limited (NASDAQ:NIVF): a thin rise with no announcement

NewGenIvf Group Limited (NASDAQ:NIVF) works in fertility services and invests in technology. The stock gained 21.30% to USD 1.40, implying a prior close near USD 1.15. No dated company news surfaced on or just before Wednesday, October 28, 2026. Its last release, from Wednesday, September 30, 2026, described closing an offering of about USD 1.25 million at USD 0.07 per share, leaving a market value near USD 1.02 million on an undated basis.

At twenty times the offering price, the quote may reflect a share consolidation since then, though that remains a guess rather than a confirmed event. The company owns 10% of K25.ai and agreed to acquire a further 3% for USD 7.5 million, lifting the expected stake to 13% and roughly USD 26 million on paper. Dilution, a Nasdaq market value requirement linked to share issuance and a forbearance agreement dated Tuesday, June 16, 2026 are the key hazards.

Where Things Stand

In brief, the top five were propelled by corporate events and thin liquidity instead of profits. Ultralife Corporation (NASDAQ:ULBI) moved on a cash takeover price and Elong Power Holding Limited (NASDAQ:ELPW) on a supply contract, whereas Braiin Limited (NASDAQ:BRAI), Davion Healthcare Plc (NASDAQ:DAVI) and NewGenIvf Group Limited (NASDAQ:NIVF) advanced without any dated announcement. Only the Ultralife move is pinned to a fixed value, the USD 16.00 cash price.

Next on the calendar are the Federal Reserve decision later on Wednesday, October 28, 2026, the Ultralife tender launch, the Davion share issue on Wednesday, January 20, 2027 and the completion of NewGenIvf's extra K25.ai purchase. Quotes before the bell are snapshots that may change, and this is not investment advice.